Endothelin-1-induced arachidonic acid release by cytosolic phospholipase A2 activation in rat vascular smooth muscle via extracellular signal-regulated kinases pathway. 2002

Lucia Trevisi, and Sergio Bova, and Gabriella Cargnelli, and Giulio Ceolotto, and Sisto Luciani
Department of Pharmacology and Anaesthesiology, University of Padua, Largo E. Meneghetti 2, 35131, Padua, Italy.

The present study investigates whether endothelin-1 (ET-1), like noradrenaline (NA), stimulates the release of arachidonic acid (AA) via cytosolic phospholipase A2 (cPLA2) in rat tail artery. In tail artery segments labelled with [3H]AA, ET-1-induced AA release in a concentration-dependent manner with an EC50 of 1.3 nM. The effect of ET-1 was inhibited by bosentan and was insensitive to BQ788, suggesting the involvement of ETA receptor. The stimulation of AA release induced by ET-1 was prevented by arachydonyl trifluoromethyl ketone (AACOCF3), a selective inhibitor of cPLA2 and not by RHC80267, a diacylglycerol lipase inhibitor. Furthermore, PD98059, inhibitor of mitogen-activated protein kinase kinase (MEK) cascade and calphostin C, a protein kinase C (PKC) inhibitor, prevented the stimulation of AA release induced by ET-1 and NA. Immunoblotting of the cytosolic fraction of rat tail arteries stimulated with ET-1 or NA showed an increase in extracellular signal-regulated kinases (ERKs) phosphorylation and this effect was abolished by calphostin C treatment. These findings show that in rat tail artery ET-1 and NA induce a sequential activation of protein kinase C and extracellular signal-regulated kinases that results in stimulation of AA release via cPLA2 activation. This may represent a general pathway by which G-proteins coupled receptors stimulate AA release and its metabolites in vascular smooth muscle.

UI MeSH Term Description Entries
D008297 Male Males
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D003512 Cyclohexanones Cyclohexane ring substituted by one or more ketones in any position.
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme

Related Publications

Lucia Trevisi, and Sergio Bova, and Gabriella Cargnelli, and Giulio Ceolotto, and Sisto Luciani
March 1999, Journal of leukocyte biology,
Lucia Trevisi, and Sergio Bova, and Gabriella Cargnelli, and Giulio Ceolotto, and Sisto Luciani
March 1991, Current eye research,
Lucia Trevisi, and Sergio Bova, and Gabriella Cargnelli, and Giulio Ceolotto, and Sisto Luciani
October 1992, FEBS letters,
Lucia Trevisi, and Sergio Bova, and Gabriella Cargnelli, and Giulio Ceolotto, and Sisto Luciani
January 1989, Biochemical and biophysical research communications,
Lucia Trevisi, and Sergio Bova, and Gabriella Cargnelli, and Giulio Ceolotto, and Sisto Luciani
July 1992, Proceedings of the National Academy of Sciences of the United States of America,
Lucia Trevisi, and Sergio Bova, and Gabriella Cargnelli, and Giulio Ceolotto, and Sisto Luciani
November 1997, The Journal of biological chemistry,
Lucia Trevisi, and Sergio Bova, and Gabriella Cargnelli, and Giulio Ceolotto, and Sisto Luciani
January 2004, Cardiovascular research,
Lucia Trevisi, and Sergio Bova, and Gabriella Cargnelli, and Giulio Ceolotto, and Sisto Luciani
February 1995, Biochimica et biophysica acta,
Lucia Trevisi, and Sergio Bova, and Gabriella Cargnelli, and Giulio Ceolotto, and Sisto Luciani
January 2003, Journal of atherosclerosis and thrombosis,
Lucia Trevisi, and Sergio Bova, and Gabriella Cargnelli, and Giulio Ceolotto, and Sisto Luciani
May 1998, Biochimica et biophysica acta,
Copied contents to your clipboard!